β Scribed by Chapekar, Mrunal S.
No coin nor oath required. For personal study only.
Several biologic-hiomaterial combinations are currently under development in an attempt to modulate tissue or organ function in patients. The FDA regulations on combination products and the intercenter agreements among the Center for Biologics Evaluation and Research (CBER), the Center for Devices and Radiological Health (CDRH), and the Center for Drugs Evaluation and Research (CDER) provide further guidance on center jurisdiction of combination products and other products where there are jurisdictional concerns. The biological component of biologic-biomaterial combinations raises a number of issues that relate to the safety and bioactivity of the final product. For example, transmission of adventitious agents to patients via somatic cells, tissue, or cell-derived products is a major safety concern as are in vivo inflammatory responses elicited by the biomaterial component. CBER has drafted a number of "Points to Consider" documents to provide further guidance in the development of biological products. The intent of this article is to provide the highlights of the FDA regulations for combination products and the intercenter agreement between CBER and CDRH delineating the responsibilities of each center for medical device activities. In addition, the article focuses on the CBERs concerns related to the development of somatic cell-biomaterial combinations for therapeutic use. @.' 1996
π SIMILAR VOLUMES
There is a growing awareness of the importance of involving the parents in all stages of the educational process for their trainable mentally handicapped (TMH) children. In this context, in-depth interviews were conducted with 10 parents of TMH adolescents, to investigate concerns, hopes and fears f
## Abstract Early prediction of human intestinal absorption is important in selection of potential orally administered drugs. Various computational models for prediction of the fraction of dose absorbed, __Fa__, have been developed. In 1989, a sigmoidal relationship between __Fa__ and drug absorpti
## Abstract The ability to control the dispersion of carbon nanotubes in polymers is key to most applications of nanotubeβpolymer composites. This feature article describes recent advances in methods used to disperse carbon nanotubes and considers how these methods affect dispersion on different le